Evidence map›Paper›PMID 40760319›Full record

ArticleAnnals of surgical oncology2025

Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry.

Jan Heil, Svenja Sliwinski, Jan D'Haese, Josef Fangmann, Stefan Farkas, Robert Grützmann, Matthias Glanemann, Jörg C Kalff, Sören T Mees, Arianeb Mehrabi and 12 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07556835 (Ambispective Cohort Study of Clinical and Oncologic Outcomes in Patients Undergoing Liver and Biliary Resection at San Jacopo Hospital, Pistoia), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07556835 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Ambispective Cohort Study of Clinical and Oncologic Outcomes in Patients Undergoing Liver and Biliary Resection at San Jacopo Hospital, Pistoia

TypeobservationalSponsorAzienda USL Toscana CentroRan2026 to 2036Enrolled1,000ConditionsLiver Neoplasms, Hepatobiliary Diseases, Cholangiocarcinoma, Hepatocellular Carcinoma
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jan HeilDepartment of General and Visceral Surgery, Ulm University Hospital, Ulm, Germany. jan.heil@uniklinik-ulm.de.
Svenja SliwinskiDepartment of General, Visceral, Transplant and Thoracic Surgery, University Hospital Frankfurt, Goethe University Frankfurt/Main, Frankfurt/Main, Germany.
Jan D'HaeseDepartment of General, Visceral, and Transplantation Surgery, Hospital of the LMU Munich, Ludwig- Maximilians- Universität (LMU), Munich, Germany.
Josef FangmannKRH Klinikum Siloah, Liver Center Hannover (LCH), Hannover, Germany.
Stefan FarkasDepartment of Surgery, St. Josefs- Hospital, Wiesbaden, Germany.
Robert GrützmannChirurgische Arbeitsgemeinschaft für Leber-, Galle- und Pankreaserkrankungen der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie, Berlin, Germany.
Matthias GlanemannDepartment of General Surgery, Visceral-, Vascular- and Pediatric Surgery, Saarland University Medical Center, Homburg, Germany.
Jörg C KalffDepartment of Surgery, University Hospital Bonn, Campus 1, Bonn, Germany.
Sören T MeesDepartment of General and Visceral Surgery, Dresden- Friedrichstadt General Hospital, Dresden, Germany.
Arianeb MehrabiDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Christoph MichalskiDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Johann PratschkeCharité- Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Campus Charité Mitte and Campus Virchow- Klinikum, Berlin, Germany.
Christoph ReissfelderDepartment of Surgery, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Heidelberg University, Mannheim, Germany.
Maximilian SchmedingDepartment of Surgery, Klinikum Dortmund, University Hospital of the University Witten/Herdecke, Witten, Germany.
Matthias SchwarzbachDepartment of General and Visceral Surgery, Klinikum Frankfurt Höchst, Frankfurt, Germany.
Gregor A StavrouChirurgische Arbeitsgemeinschaft für Leber-, Galle- und Pankreaserkrankungen der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie, Berlin, Germany.
Jens WernerDepartment of General, Visceral, and Transplantation Surgery, Hospital of the LMU Munich, Ludwig- Maximilians- Universität (LMU), Munich, Germany.
Carsten KlingerStuDoQ Gremium Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie, Berlin, Germany.
Heinz BuhrStuDoQ Gremium Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie, Berlin, Germany.
Wolf O BechsteinDepartment of General, Visceral, Transplant and Thoracic Surgery, University Hospital Frankfurt, Goethe University Frankfurt/Main, Frankfurt/Main, Germany.
Andreas A SchnitzbauerChirurgische Arbeitsgemeinschaft für Leber-, Galle- und Pankreaserkrankungen der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie, Berlin, Germany.
DGAV StuDoQ-Registry

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTextbook outcome (TO) represents the most desirable outcome of surgical quality and care. This study examined the TO of cholangiocarcinoma (CCC), hepatocellular carcinoma (HCC), and colorectal liver metastasis (CRLM) from the StuDoQ liver registry as well as factors that may affect the TO.

methodsAll major liver resections (≥ 3 segments) for CCC, HCC, and CRLM entered in the multicentric StuDoQ liver registry between 2019 and 2022 were retrospectively analyzed. TO was defined by the absence of intraoperative incidents ≥ grade 2 (Oslo criteria), postoperative bile leakage and posthepatectomy liver failure (B/C, ISGLS criteria), major complications (Dindo-Clavien ≥ 3A), 90-day readmission, and mortality rate as well as tumor-free resection margin. Pre- and intraoperative factors that may influence TO were assessed by multivariable analyses.

resultsIn 30 participating centers, a total of 1082 major liver resections were performed for CCC (n = 396, 36%), HCC (n = 214, 20%), and CRLM (n = 472, 44%). TO was achieved in 470 (43%) cases, most often in CRLM (51%). Major complications and intraoperative incidents ≥ 2 were the most frequent limiting factors to achieve TO. Anemia (odds ratio (OR) 0.63, 95% confidence interval (CI) 0.47-0.85), simultaneous resection procedures to the liver resection (OR 0.56, 95% CI 0.36-0.88), hyperbilirubinemia (OR 0.53, 95% CI 0.34-0.83), and cholangitis (OR 0.51, 95% CI 0.28-0.94) were identified as modifiable risk factors preventing achievement of a TO.

conclusionTO after major liver resection was achieved in less than 50% of cases in certified and high-volume HPB centers. Preoperative risk factors were identified that may allow to improve outcome quality.

Indexed as

Bile Duct NeoplasmsCarcinoma, HepatocellularCholangiocarcinomaColorectal NeoplasmsHepatectomyLiver NeoplasmsPostoperative ComplicationsAgedFemaleFollow-Up StudiesGermanyHumansMaleMiddle AgedPrognosisRegistriesCholangiocarcinomaColorectal liver metastasisHepatocellular carcinomaMajor hepatectomyOutcome qualityTextbook outcome

Identifiers

PMID40760319
PMCPMC12454482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.